The role of autoantibodies in the syndromes of orthostatic intolerance: a systematic review

References

• Fedorowski A, Melander O. Syndromes of orthostatic intolerance: a hidden danger. J Intern Med. 2013;273:322–335.
   PubMed Web of Science ®Google Scholar
• Grubb BP. Postural tachycardia syndrome. Circulation. 2008;117:2814–2817.
   PubMed Web of Science ®Google Scholar
• Li H, Yu X, Liles C, et al. Autoimmune basis for postural tachycardia syndrome. J Am Heart Assoc. 2014;3:e000755.
   PubMed Web of Science ®Google Scholar
• Tomljenovic L, Colafrancesco S, Perricone C, et al. Postural orthostatic tachycardia with chronic fatigue after HPV vaccination as part of the 'autoimmune/auto-inflammatory syndrome induced by adjuvants': case report and literature review. J Investig Med High Impact Case Rep. 2014;2:2324709614527812.
   Google Scholar
• Blitshteyn S. Postural tachycardia syndrome following human papillomavirus vaccination. Eur J Neurol. 2014;21:135–139.
   PubMed Web of Science ®Google Scholar
• Kanjwal K, Karabin B, Sheikh M, et al. New onset postural orthostatic tachycardia syndrome following ablation of AV node reentrant tachycardia. J Interv Card Electrophysiol. 2010;29:53–56.
   PubMed Web of Science ®Google Scholar
• Dupond JL, Gil H, Bouhaddi M, et al. Acute dysautonomia secondary to autoimmune diseases: efficacy of intravenous immunoglobulin and correlation with a stimulation of plasma norepinephrine levels. Clin Exp Rheumatol. 1999;17:733–736.
   PubMed Web of Science ®Google Scholar
• Ishitobi M, Haginoya K, Kitamura T, et al. Acute dysautonomia: complete recovery after two courses of IVIg. Brain Dev. 2004;26:542–544.
   PubMed Web of Science ®Google Scholar
• Kanjwal K, Karabin B, Kanjwal Y, et al. Autonomic dysfunction presenting as postural orthostatic tachycardia syndrome in patients with multiple sclerosis. Int J Med Sci. 2010;7:62–67.
   PubMed Web of Science ®Google Scholar
• Blitshteyn S. Autoimmune markers and autoimmune disorders in patients with postural tachycardia syndrome (POTS). Lupus. 2015;24:1364–1369.
   PubMed Web of Science ®Google Scholar
• Vernino S, Low PA, Fealey RD, et al. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med. 2000;343:847–855.
   PubMed Web of Science ®Google Scholar
• Thieben MJ, Sandroni P, Sletten DM, et al. Postural orthostatic tachycardia syndrome: the Mayo clinic experience. Mayo Clin Proc. 2007;82:308–313.
   PubMed Web of Science ®Google Scholar
• McKeon A, Lennon VA, Lachance DH, et al. Ganglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompaniments. Arch Neurol. 2009;66:735–741.
   PubMedGoogle Scholar
• Cutsforth-Gregory J, Coon E, McKeon A, et al. Dysautonomia due to ganglionic nicotinic acetylcholine receptor autoimmunity (S18. 007). Neurol Clin Pract. 2016;86:S18.007.
   Google Scholar
• Yu X, Stavrakis S, Hill MA, et al. Autoantibody activation of beta-adrenergic and muscarinic receptors contributes to an 'autoimmune' orthostatic hypotension: receptor autoantibodies in orthostatic hypotension. J Am Soc Hypertension. 2012;6:40–47.
   PubMed Web of Science ®Google Scholar
• Strosberg AD. Structure, function, and regulation of adrenergic receptors. Protein Sci. 1993;2:1198–1209.
   PubMed Web of Science ®Google Scholar
• Taylor MRG. Pharmacogenetics of the human beta-adrenergic receptors. Pharmacogenom J. 2006;7:29–37.
   PubMed Web of Science ®Google Scholar
• Osborn JL, DiBona GF, Thames MD. Beta-1 receptor mediation of renin secretion elicited by low-frequency renal nerve stimulation. J Pharmacol Exp Ther. 1981;216:265–269.
   PubMed Web of Science ®Google Scholar
• Overgaard CB, Džavík V. Inotropes and vasopressors: review of physiology and clinical use in cardiovascular disease. Circulation. 2008;118:1047–1056.
   PubMed Web of Science ®Google Scholar
• Kanagy Nancy L. α2-Adrenergic receptor signalling in hypertension. Clin Sci. 2005;109:431–437.
   PubMed Web of Science ®Google Scholar
• Philipp M, Brede M, Hein L. Physiological significance of α2-adrenergic receptor subtype diversity: one receptor is not enough. Am J Physiol Regul Integr Comp Physiol. 2002;283:R287–R295.
   PubMed Web of Science ®Google Scholar
• Taylor MRG, Bristow MR. The emerging pharmacogenomics of the β-adrenergic receptors. Congest Heart Fail. 2004;10:281–288.
   PubMedGoogle Scholar
• Gauthier C, Tavernier G, Charpentier F, et al. Functional beta3-adrenoceptor in the human heart. J Clin Invest. 1996;98:556–562.
   PubMed Web of Science ®Google Scholar
• Li H, Kem DC, Reim S, et al. Agonistic autoantibodies as vasodilators in orthostatic hypotension: a new mechanism. Hypertension. 2012;59:402–408.
   PubMed Web of Science ®Google Scholar
• Fedorowski A, Li H, Yu X, et al. Antiadrenergic autoimmunity in postural tachycardia syndrome. Europace. 2016.
   Web of Science ®Google Scholar
• Lennon VA, Ermilov LG, Szurszewski JH, et al. Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease. J Clin Invest. 2003;111:907–913.
   PubMed Web of Science ®Google Scholar
• Vernino S, Low PA, Lennon VA. Experimental autoimmune autonomic neuropathy. J Neurophysiol. 2003;90:2053–2059.
   PubMed Web of Science ®Google Scholar
• Sandroni P, Vernino S, Klein CM, et al. Idiopathic autonomic neuropathy: comparison of cases seropositive and seronegative for ganglionic acetylcholine receptor antibody. Arch Neurol. 2004;61:44–48.
   PubMedGoogle Scholar
• Gibbons CH, Freeman R. Antibody titers predict clinical features of autoimmune autonomic ganglionopathy. Auton Neurosci. 2009;146:8–12.
   PubMed Web of Science ®Google Scholar
• Wang X-L, Chai Q, Charlesworth MC, et al. Autoimmunoreactive IgGs from patients with postural orthostatic tachycardia syndrome. Prot Clin Appl. 2012;6:615–625.
   PubMed Web of Science ®Google Scholar
• Wallukat GNE, Morwinski R, Müller J. Autoantibodies against the beta- and muscarinic receptors in cardiomyopathy. Herz. 2000;25:261–266.
   PubMed Web of Science ®Google Scholar
• Stavrakis S, Kem DC, Patterson E, et al. Opposing cardiac effects of autoantibody activation of β-adrenergic and M2 muscarinic receptors in cardiac-related diseases. Int J Cardiol. 2011;148:331–336.
   PubMed Web of Science ®Google Scholar
• Yu X, Patterson E, Stavrakis S, et al. Development of cardiomyopathy and atrial tachyarrhythmias associated with activating autoantibodies to beta-adrenergic and muscarinic receptors. J Am Soc Hypertension. 2009;3:133–140.
   PubMed Web of Science ®Google Scholar
• Magnusson Y, Wallukat G, Waagstein F, et al. Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect. Circulation. 1994;89:2760–2767.
   PubMed Web of Science ®Google Scholar
• Limas CJ, Limas C. Beta-adrenoceptor antibodies and genetics in dilated cardiomyopathy-an overview and review. Eur Heart J. 1991;12(Suppl D):175–177.
   PubMed Web of Science ®Google Scholar
• Wenzel KHH, Wallukat G, Derer W, et al. Potential relevance of alpha(1)-adrenergic receptor autoantibodies in refractory hypertension. PLoS One. 2008;3:e3742.
   PubMed Web of Science ®Google Scholar
• Fu MLHH, Wallukat G, Hilme E, et al. Functional autoimmune epitope on alpha 1-adrenergic receptors in patients with malignant hypertension. Lancet. 1994;344:1660–1663.
   PubMed Web of Science ®Google Scholar
• Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003;349:1526–1533.
   PubMed Web of Science ®Google Scholar
• Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365:2110–2121.
   PubMed Web of Science ®Google Scholar
• Gibbons CH, Vernino SA, Kaufmann H, et al. L-DOPS therapy for refractory orthostatic hypotension in autoimmune autonomic neuropathy. Neurology. 2005;65:1104–1106.
   PubMed Web of Science ®Google Scholar
• Modoni A, Mirabella M, Madia F, et al. Chronic autoimmune autonomic neuropathy responsive to immunosuppressive therapy. Neurology. 2007;68:161–162.
   PubMed Web of Science ®Google Scholar
• Gibbons CH, Vernino SA, Freeman R. Combined immunomodulatory therapy in autoimmune autonomic ganglionopathy. Arch Neurol. 2008;65:213–217.
   PubMedGoogle Scholar